ADIM
EHC icon

Alpha DNA Investment Management’s Encompass Health EHC Stock Holding History

Alpha DNA Investment Management’s Portfolio EHC Stock Details EHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-7,738
Closed -$639K – 215
2024
Q1 		$639K Buy
+7,738
New +$567K 0.24% 91

Other funds holding EHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Alpha DNA Investment Management's EHC Position: Q2 2024 in Review

Alpha DNA Investment Management sold out of Encompass Health (EHC) in Q2 2024, closing a stake of 7,738 shares — an estimated $639K sold.

Alpha DNA Investment Management first reported a position in EHC in Q1 2024 and held it in 1 quarter. The position peaked at $639K in Q1 2024. 477 funds tracked by Wall St. Rank hold EHC as of Q2 2024.

  • Alpha DNA Investment Management reported no remaining Encompass Health position as of Q2 2024 after selling out during the quarter.
  • Alpha DNA Investment Management sold 7,738 Encompass Health shares in Q2 2024, an estimated $639K.
  • Alpha DNA Investment Management first reported a position in Encompass Health in Q1 2024 and held it in 1 quarter.
  • Alpha DNA Investment Management's Encompass Health position peaked at $639K in Q1 2024.
  • 477 funds tracked by Wall St. Rank held Encompass Health as of Q2 2024.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.